… However, whether gefitinib, erlotinib, or afatinib is most … study was to compare the effectiveness
of gefitinib, erlotinib, and afatinib. We retrospectively reviewed the records of 310 patients …

… based on individual patient data, and not all studies provided detailed subgroups analysis.
… This study investigated maintenance gemcitabine or erlotinib versus observation, following …

… The purpose of this study was to investigate the outcomes of gefitinib and erlotinib in patients
… In this study, patients treated with gefitinib had a significantly better ORR and longer PFS …

… This value is much lower than the penetration of erlotinib measured in this study (ranging
from 2.5 to 13.3%). Although the oral bioavailabilities are reported as almost equal between …

… , gefitinib, erlotinib and icotinib had similar effectiveness for the treatment of patients with …
In the current study, a network meta-analysis was performed to compare the effectiveness …

… was more effective in obtaining cytologic negative conversion of the CSF than gefitinib for a
subgroup of patients. The results of this study suggest that erlotinib provides better control of …

… in this study of erlotinib. One-year survival rate for patients treated with gefitinib was 32% (95…
than the rate reported here for erlotinib, although CIs for both studies were large. Similar to …

… Eight randomized trials and 82 cohort studies with a total of 17,621 patients were included
for analysis. Gefitinib and erlotinib demonstrated comparable effects on progression-free …

… patients treated with first-line afatinib, gefitinib, or erlotinib for … Our purpose of this study is
to investigate how afatinib is used in … clinical outcomes compared with gefitinib or erlotinib. …

… , phase III study of single-agent erlotinib at a dose of 150 mg daily in patients with locally …
Interestingly, the HRs for erlotinib in the two patient subsets in which gefitinib appears to …